Technology & Biotech

Stem Pharm wins $1.7 million brain model grant

Madison-based biotechnology firm Stem Pharm has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health.

Madison ranks high for women in STEM jobs

Achieving greater diversity in the STEM fields of science, technology, engineering, and mathematics has long been an uphill battle, but signs are pointing to steady — albeit noticeably slow — growth in the number of women being employed in the sector. Perhaps not surprisingly, Madison is helping lead the way.

BellBrook awarded $300,000 for tumor research

Fitchburg-based BellBrook Labs has been awarded a $300,000 Phase I Small Business Innovative Research grant to develop and validate HTS assays for the discovery of small-molecule antagonists of TREX1.

WARF startup receives National Science Foundation grant

Madison-based Pyran Inc. has received a $1 million Phase II Small Business Innovative Research grant from the National Science Foundation to promote the company’s work to make paints and coatings from renewable sources like corn cobs.

Health tracker app gains users

An internally developed tool from M3 Insurance aimed at helping commercial clients facilitate a safe return to work is gaining traction.

Local tech organization nationally recognized

Madison-based Wisconsin Center for Technology Commercialization (CTC) has received an award from the U.S. Small Business Administration for achieving significant economic impact in advancing small technology businesses.

Cellectar treatment earns ‘orphan drug’ designation in Europe

Cellectar Biosciences Inc., a Madison-based company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, announced that the European Medicines Agency has adopted a positive opinion for CLR 131 orphan designation for Cellectar’s treatment for Waldenstrom’s Macroglobulinemiam, a rare blood cancer.

In Business magazine